Physician profile
Jerry L Cade
NPI 1346311354
$179,920.90
in general payments reported to CMS, 2019-2025
8 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $8,784 · 2021: $38K · 2022: $28K · 2023: $39K · 2024: $14K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Consulting Fee: $20K · Travel and Lodging: $5,234 · Food and Beverage: $4,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,965.00 |
| Consulting Fee | $20,000.00 |
| Travel and Lodging | $5,233.53 |
| Food and Beverage | $4,417.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $95,302.45 | 2019-2025 | Biktarvy, Epclusa, Descovy |
| Viiv Healthcare Company | $50,759.20 | 2019-2025 | Cabenuva, Dovato, Apretude |
| Merck Sharp & Dohme LLC | $29,967.21 | 2019-2025 | Pifeltro, Delstrigo, Capvaxive |
| Roche Diagnostics Corporation | $3,772.90 | 2019 | |
| Abbvie INC. | $74.14 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $16.91 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Napo Pharmaceuticals INC | $16.66 | 2024 | Mytesi |
| Dynasplint Systems INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Cade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.